InMed Pharmaceuticals (INM) Goodwill (2021 - 2023)

InMed Pharmaceuticals has reported Goodwill for 3 years, with the latest figure at $1.1 million in Q2 2023.

• For the quarter ending Q2 2023, Goodwill fell 5.79% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2023 stood at $1.1 million (down 5.79% YoY), and the FY2023 full-year result was $1.1 million, down 5.79% from the prior year.
• Goodwill for Q2 2023 stood at $1.1 million, down from $1.1 million in the prior quarter.
• The five-year high for Goodwill was $2.0 million in Q4 2021, with the low at $1.1 million in Q2 2023.
• Historically, Goodwill has averaged $1.6 million across 3 years, with a median of $1.7 million in 2021.
• Annual changes were most pronounced in 2022 — Goodwill sank 34.14% — and 2023, when it decreased 5.79%.
• InMed Pharmaceuticals' Goodwill stood at $2.0 million in 2021, then tumbled by 43.47% to $1.1 million in 2022, then dropped by 5.79% to $1.1 million in 2023.
• The last three Goodwill figures came in at $1.1 million (Q2 2023), $1.1 million (Q2 2022), and $2.0 million (Q1 2022), per Business Quant data.